January 26, 2017
3 min watch
Save

VIDEO: Analyses show potential cost savings of ROP screening, treatment program

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

KOLOA, Hawaii ― At Retina 2017, Timothy W. Olsen, MD, discusses the economic impact of implementing a nationalized program of screening and treatment for retinopathy of prematurity.